Dry Eye and Refractive Surgery Outcomes

Abstract
The purpose of this study is to review effective diagnostic and management strategies for dry eye disease (DED) and technological advances in refractive surgery for improving patient satisfaction and surgical outcomes. In addition to clinical examination and previously used diagnostic tools for DED, newer devices can now allow for earlier detection by measuring surrogate markers for DED and meibomian gland dysfunction. These markers include lipid layer thickness, tear film breakup time, tear osmolarity, and matrix metalloproteinase-9 levels. There continues to also be evolution of newer corneal refractive procedures such as corneal inlays and small-incision lenticular extraction. DED affects millions worldwide and negatively affects vision quality and refractive surgery outcomes. It is critical to effectively diagnose and manage patients with DED, prior to undergoing refractive surgery. Advances in both DED management and surgical technology are making it easier to offer patients the refractive outcomes they desire.

Source: Current Ophthalmology Reports - January 22, 2016 Category: Opthalmology Source Type: research